ADDITION is a multi-factorial intervention study, which primarily focuses on cardiovascular morbidity and mortality among people with screen-detected type-2 diabetes in the UK, the Netherlands and Denmark.
Several analyses have been conducted for all three involved countries under the acronym ADDITION-EUROPE. Some analyses were done for the separate centres under the following acronyms: ADDITION-Cambridge, ADDITION-Leicester, ADDITION-Netherlands, ADDITION-Denmark and ADDITION-PRO.